Phocas Financial Corp. Amgen Inc Transaction History

Phocas Financial Corp.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 10, 2023	BUY	$229.03 - $291.01 $137,418 - $174,606	600 New	600 $0
Q3 2019 Nov 15, 2019	SELL	$174.11 - $208.62 $104,466 - $125,172	-600 Closed	0 $0
Q2 2019 Aug 16, 2019	BUY	$166.7 - $195.41 $100,020 - $117,246	600 New	600 $0
Q1 2019 May 13, 2019	SELL	$180.87 - $203.88 $108,522 - $122,328	-600 Closed	0 $0
Q4 2018 Feb 15, 2019	BUY	$178.4 - $208.25 $107,040 - $124,950	600 New	600 $117,000

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Phocas Financial Corp., based on Form 13F filings with the SEC.

Stay updated on Phocas Financial Corp. with notifications on news.